Status:
COMPLETED
The Effect of TRA-8 on Ovarian Cancer Tissue
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
19+ years
Brief Summary
The goal of this study is to determine the apoptosis-inducing efficacy of TRA-8 in patient ovarian cancer tissues using a tissue slice technology. In addition, we want to evaluate the expression of ap...
Detailed Description
Ovarian cancer remains highly lethal, with an estimated 25,580 new cases and 16,090 death per year in the US. The most common ovarian cancers arise from the surface epithelium of the ovary. Approximat...
Eligibility Criteria
Inclusion
- Patients must have suspected ovarian cancer and must be a candidate for surgery.
- Patients must have provided a signed consent form.
- Patients must have extra tumor at the time of surgery that is appropriate for tumor slicing.
- Patients must be at least 19 years of age.
- Patients must have histologically confirmed epithelial carcinoma of the ovary or of extra-ovarian origin, any histologic subtype or stage.
Exclusion
- Patients who have received any prior therapy for ovarian cancer.
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
478 Patients enrolled
Trial Details
Trial ID
NCT00711932
Start Date
August 1 2008
End Date
January 1 2013
Last Update
September 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama
Birmingham, Alabama, United States, 35294